• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea.GxAlert对巴布亚新几内亚莫尔斯比港耐利福平结核病患者管理的影响
Public Health Action. 2019 Sep 21;9(Suppl 1):S19-S24. doi: 10.5588/pha.18.0067.
2
Effects of Xpert MTB/RIF testing and GxAlert on MDR-TB diagnosis and linkage to care in Mozambique.Xpert MTB/RIF 检测和 GxAlert 对莫桑比克耐多药结核病诊断和治疗关联的影响。
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1358-1365. doi: 10.5588/ijtld.17.0901.
3
Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.在巴布亚新几内亚疑似肺结核儿童中对Xpert MTB/RIF检测法的评估。
Paediatr Int Child Health. 2018 May;38(2):97-105. doi: 10.1080/20469047.2017.1319898. Epub 2017 May 11.
4
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.GeneXpert MTB/RIF®对俄罗斯弗拉基米尔结核病防治所耐利福平及利福平敏感结核病患者治疗起始及治疗结果的影响。
BMC Infect Dis. 2020 Jul 25;20(1):543. doi: 10.1186/s12879-020-05243-9.
5
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.Xpert MTB/RIF和分散式护理对南非约翰内斯堡结核病治疗的就医关联及耐多药结核病治疗结果的影响
BMC Health Serv Res. 2018 Dec 17;18(1):973. doi: 10.1186/s12913-018-3762-x.
6
Scale-up and impact of digital and molecular diagnostic technologies on TB diagnosis and timely linkage to care in Tajikistan.数字和分子诊断技术在塔吉克斯坦的推广及其对结核病诊断和及时获得治疗的影响。
J Infect Dev Ctries. 2021 Sep 29;15(9.1):58S-65S. doi: 10.3855/jidc.13758.
7
Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.南非实施Xpert MTB/RIF后耐多药结核病治疗前的延误和失访:一项回顾性队列研究。
PLoS Med. 2017 Feb 21;14(2):e1002238. doi: 10.1371/journal.pmed.1002238. eCollection 2017 Feb.
8
High prevalence of pulmonary tuberculosis among female sex workers, men who have sex with men, and transgender women in Papua New Guinea.在巴布亚新几内亚,女性性工作者、男男性行为者和变性女性中肺结核的高患病率。
Trop Med Health. 2021 Jan 13;49(1):4. doi: 10.1186/s41182-020-00293-w.
9
Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients' linkage to care in Tanzania.评估GeneXpert GxAlert平台在坦桑尼亚用于耐多药结核病诊断及患者与医疗服务的关联情况。
BMC Res Notes. 2018 Feb 9;11(1):121. doi: 10.1186/s13104-018-3235-7.
10
Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.评估 Xpert MTB-RIF 指导下的耐利福平结核病的诊断和治疗:一项回顾性队列研究。
PLoS One. 2019 Feb 28;14(2):e0213017. doi: 10.1371/journal.pone.0213017. eCollection 2019.

引用本文的文献

1
Sputum culture contamination and associated characteristics in a diagnostic clinical trial, Papua New Guinea.巴布亚新几内亚一项诊断性临床试验中的痰液培养污染及相关特征
Public Health Action. 2024 Dec 1;14(4):152-157. doi: 10.5588/pha.24.0029. eCollection 2024 Dec.
2
Drug-resistant TB in Morobe Province, Papua New Guinea, 2012-2021.2012 - 2021年,巴布亚新几内亚莫罗贝省的耐药结核病
Public Health Action. 2024 Dec 1;14(4):146-151. doi: 10.5588/pha.24.0011. eCollection 2024 Dec.
3
Loss to follow-up among adults with drug-resistant TB in Papua New Guinea.巴布亚新几内亚耐药结核病成人患者的失访情况。
Public Health Action. 2024 Sep 1;14(3):85-90. doi: 10.5588/pha.24.0004. eCollection 2024 Sep.
4
Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012-2019: Are We on the Right Track?乌兹别克斯坦 2012-2019 年耐药结核病分子诊断检测扩大化:我们是否走在正确的轨道上?
Int J Environ Res Public Health. 2021 Apr 28;18(9):4685. doi: 10.3390/ijerph18094685.
5
Drug-resistant tuberculosis diagnosis since Xpert MTB/RIF introduction in Papua New Guinea, 2012-2017.2012 - 2017年巴布亚新几内亚引入Xpert MTB/RIF后耐药结核病的诊断情况
Public Health Action. 2019 Sep 21;9(Suppl 1):S12-S18. doi: 10.5588/pha.19.0005.

本文引用的文献

1
Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.印度古吉拉特邦五个地区耐多药结核病患者在开始治疗前的延误和治疗中断情况。
Public Health Action. 2018 Jun 21;8(2):59-65. doi: 10.5588/pha.18.0003.
2
Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.基于社区的耐多药结核病护理项目提高了缅甸耐多药结核病患者的治疗启动率。
PLoS One. 2018 Mar 29;13(3):e0194087. doi: 10.1371/journal.pone.0194087. eCollection 2018.
3
Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients' linkage to care in Tanzania.评估GeneXpert GxAlert平台在坦桑尼亚用于耐多药结核病诊断及患者与医疗服务的关联情况。
BMC Res Notes. 2018 Feb 9;11(1):121. doi: 10.1186/s13104-018-3235-7.
4
Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India.耐多药结核病患者诊断前流失率低但治疗前流失率高:来自印度金奈的一项运筹学研究。
J Epidemiol Glob Health. 2017 Dec;7(4):227-233. doi: 10.1016/j.jegh.2017.07.001. Epub 2017 Jul 6.
5
Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.利福平耐药结核病的治疗时间:系统评价和荟萃分析。
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1173-1180. doi: 10.5588/ijtld.17.0230.
6
Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial.即时检测Xpert MTB/RIF对结核病治疗启动的影响。一项整群随机试验。
Am J Respir Crit Care Med. 2017 Oct 1;196(7):901-910. doi: 10.1164/rccm.201702-0278OC.
7
Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes?为什么Xpert® MTB/RIF的临床试验未能显示出对患者相关结局的影响?
Int J Tuberc Lung Dis. 2017 Mar 1;21(3):249-250. doi: 10.5588/ijtld.16.0801.
8
Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.南非实施Xpert MTB/RIF后耐多药结核病治疗前的延误和失访:一项回顾性队列研究。
PLoS Med. 2017 Feb 21;14(2):e1002238. doi: 10.1371/journal.pmed.1002238. eCollection 2017 Feb.
9
Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?Xpert MTB/RIF——干预试验中为何缺乏对发病率和死亡率的影响?
Trans R Soc Trop Med Hyg. 2016 Aug;110(8):432-44. doi: 10.1093/trstmh/trw056. Epub 2016 Sep 16.
10
Outbreak of multidrug-resistant tuberculosis on Daru Island: an update.达鲁岛耐多药结核病疫情:最新情况
Lancet Respir Med. 2016 Aug;4(8):e40. doi: 10.1016/S2213-2600(16)30094-7. Epub 2016 Jun 21.

GxAlert对巴布亚新几内亚莫尔斯比港耐利福平结核病患者管理的影响

Impact of GxAlert on the management of rifampicin-resistant tuberculosis patients, Port Moresby, Papua New Guinea.

作者信息

Banamu J K, Lavu E, Johnson K, Moke R, Majumdar S S, Takarinda K C, Commons R J

机构信息

Central Public Health Laboratory, Port Moresby, Papua New Guinea (PNG).

Health and HIV Implementation Services Provider, Port Morseby, PNG.

出版信息

Public Health Action. 2019 Sep 21;9(Suppl 1):S19-S24. doi: 10.5588/pha.18.0067.

DOI:10.5588/pha.18.0067
PMID:31579645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6735454/
Abstract

SETTING

GxAlert is an automatic electronic notification service that provides immediate Xpert MTB/RIF testing results. It was implemented for the notification of patients with rifampicin resistant-tuberculosis (RR-TB) at Port Moresby General Hospital, Port Moresby, Papua New Guinea, in May 2015.

OBJECTIVE

To determine if there were differences in pre-treatment attrition, the time to treatment initiation and patient outcomes in the 12 months pre- and post-introduction of GxAlert for RR-TB patients.

DESIGN

This was a retrospective cohort study.

RESULTS

The median time from Xpert testing to treatment initiation decreased from 35 days [IQR 13-131] prior to GxAlert to 10 days [IQR 3-29] after GxAlert ( = 0.001), with the cumulative proportion of patients initiating treatment within 30 days increasing from 25% (95%CI 17-37) to 54% (95%CI 44-64; < 0.001) over these periods. However, our analysis of the time to treatment prior to the introduction of GxAlert suggests that a decrease had already occurred prior to implementation. There was no difference in interim clinical outcomes between the periods.

CONCLUSION

Although a decrease in time to treatment initiation cannot be attributed to GxAlert, there was a significant improvement over the 2-year period, suggesting that considerable improvements have been made in timely RR-TB patient management in Port Moresby.

摘要

背景

GxAlert是一项自动电子通知服务,可提供即时的Xpert MTB/RIF检测结果。2015年5月,该服务在巴布亚新几内亚莫尔斯比港的莫尔斯比港总医院实施,用于通知耐利福平结核病(RR-TB)患者。

目的

确定在引入GxAlert前后12个月内,RR-TB患者的治疗前流失率、开始治疗的时间和患者预后是否存在差异。

设计

这是一项回顾性队列研究。

结果

从Xpert检测到开始治疗的中位时间从GxAlert引入前的35天[四分位间距13 - 131]降至引入后的10天[四分位间距3 - 29](P = 0.001),在此期间,30天内开始治疗的患者累积比例从25%(95%置信区间17 - 37)增至54%(95%置信区间44 - 64;P < 0.001)。然而,我们对引入GxAlert之前治疗时间的分析表明,在实施之前就已经出现了下降。两个时期的中期临床结果没有差异。

结论

虽然开始治疗时间的缩短不能归因于GxAlert,但在两年期间有显著改善,这表明莫尔斯比港在RR-TB患者的及时管理方面取得了相当大的进步。